ALTERITY THERAPEUTICS LTD (ATHE) — Institutional Holders, Q2 2026
22 institutional investment managers reported a ATHE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.1M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ATHE in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
7
Added to
7
Trimmed
0
Sold out
0
Biggest buyers
- GREENLEAFAdded · +30,000 sh+$161.1K
- CITADEL ADVISORSAdded · +17,520 sh+$94.1K
- HRT FINANCIALNew · +17,292 sh+$92.9K
- MORGAN STANLEYAdded · +4,683 sh+$25.1K
- BNP PARIBAS FINANCIAL MARKETSAdded · +3,430 sh+$18.4K
Biggest sellers
None this quarter.
ATHE 13F holders ranked 1–22 of 22
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Twin Lakes Capital Management#1 · 139,258 sh | 139,258 | $747.8K | 0.29% | 0.0% |
| 2 | MORGAN STANLEY#2 · 63,065 sh | 63,065 | $338.7K | 0.00% | +8.0% |
| 3 | GREENLEAF#3 · 62,000 sh | 62,000 | $332.9K | <0.01% | +93.8% |
| 4 | HB Wealth Management#4 · 58,460 sh | 58,460 | $313.9K | — | 0.0% |
| 5 | CITADEL ADVISORS#5 · 37,597 sh | 37,597 | $201.9K | 0.00% | +87.3% |
| 6 | HRT FINANCIAL#6 · 17,292 sh | 17,292 | $92.0K | <0.01% | New |
| 7 | BNP PARIBAS FINANCIAL MARKETS#7 · 10,239 sh | 10,239 | $55.0K | 0.00% | +50.4% |
| 8 | GAMMA Investing#8 · 2,309 sh | 2,309 | $12.4K | — | +24.4% |
| 9 | RHUMBLINE ADVISERS#9 · 2,009 sh | 2,009 | $10.8K | 0.00% | +2.0% |
| 10 | ACADIAN ASSET MANAGEMENT#10 · 1,863 sh | 1,863 | $10.0K | 0.00% | 0.0% |
| 11 | Providence Capital Advisors#11 · 200 sh | 200 | $1.1K | <0.01% | New |
| 12 | Integrated Wealth Concepts#12 · 73 sh | 73 | $392.00 | 0.00% | New |
| 13 | OSAIC#13 · 68 sh | 68 | $362.00 | 0.00% | 0.0% |
| 14 | Ronald Blue#14 · 40 sh | 40 | $215.00 | — | 0.0% |
| 15 | Farther Finance Advisors#15 · 39 sh | 39 | $205.00 | — | +77.3% |
| 16 | CoreCap Advisors#16 · 21 sh | 21 | $113.00 | — | 0.0% |
| 17 | Steward Partners Investment Advisory#17 · 6 sh | 6 | $32.00 | 0.00% | 0.0% |
| 18 | UBS Group AG#18 · 5 sh | 5 | $27.00 | 0.00% | New |
| 19 | Cranbrook Wealth Management#19 · 1 sh | 1 | $6.00 | 0.00% | New |
| 20 | Caitong International Asset Management , Ltd#20 · 1 sh | 1 | $5.00 | 0.00% | New |
| 21 | DANSKE BANK A/S#21 · 1 sh | 1 | $5.00 | 0.00% | 0.0% |
| 22 | CITIGROUP#22 · 1 sh | 1 | $5.00 | 0.00% | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.